Items where authors include "Molyneux, A."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Poyraz, O. orcid.org/0000-0001-9892-5738, Tomlinson, D. orcid.org/0000-0003-2184-2357, Molyneux, A. orcid.org/0000-0002-3289-3718 et al. (3 more authors) (2025) Optimized and additively manufactured face mills for enhanced cutting performance. Metals, 15 (4). 376. ISSN 2075-4701
Yasa, E. orcid.org/0000-0001-5443-3598, Poyraz, O. orcid.org/0000-0001-9892-5738, Do, K. et al. (3 more authors) (2025) In-situ monitoring and control of additive friction stir deposition. Materials, 18 (7). 1509. ISSN 1996-1944
Zhao, X., Eren, O.C. orcid.org/0000-0002-2665-3611, Molyneux, A. et al. (3 more authors) (2025) Development of a methodology for in vitro and in silico simulation of transcatheter aortic valve replacement using 3D-printed valve frames. Computers in Biology and Medicine, 186. 109690. ISSN 0010-4825
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Yasa, E. orcid.org/0000-0001-5443-3598, Poyraz, O. orcid.org/0000-0001-9892-5738, Molyneux, A. orcid.org/0000-0002-3289-3718 et al. (3 more authors) (2024) Systematic review on additive friction stir deposition: materials, processes, monitoring and modelling. Inventions, 9 (6). 116. ISSN 2411-5134
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Up a level